About Stamm Biotech
Stamm Biotech is a company based in San Francisco (United States) founded in 2017. Stamm Biotech has raised $17.25 million across 2 funding rounds from investors including GRIDX, Vista Equity Partners and Abundance Venture Capital. Stamm Biotech offers products and services including Bioprocessor, Bioengineering Solutions, and Bio AI Pipelines. Stamm Biotech operates in a competitive market with competitors including MaxCyte, SQZBiotech, Fluxion Biosciences, Berkeley Lights and LBT Innovations, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.25 M (USD)
in 2 rounds
-
Latest Funding Round
$17 M (USD), Series A
Mar 01, 2022
-
Investors
GRIDX
& 11 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stamm Biotech
Stamm Biotech offers a comprehensive portfolio of products and services, including Bioprocessor, Bioengineering Solutions, and Bio AI Pipelines.
Automated system for continuous biologics and cell therapies production.
End-to-end support for clinical and commercial manufacturing processes.
AI models for predicting cell behavior from multi-omics data.
People of Stamm Biotech
Unlock access to complete
Funding Insights of Stamm Biotech
Stamm Biotech has successfully raised a total of $17.25M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $17 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Stamm Biotech
Stamm Biotech has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include GRIDX, Vista Equity Partners and Abundance Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed toward high-growth enterprise software and technology companies.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Locked | Locked | Locked |
Investor details for Stamm Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Stamm Biotech
Investment portfolio details for Stamm Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Stamm Biotech
Detailed financials for Stamm Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stamm Biotech Comparisons
Peer comparison for Stamm Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Stamm Biotech
Stamm Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MaxCyte, SQZBiotech, Fluxion Biosciences, Berkeley Lights and LBT Innovations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instrument systems for cell processing and modification are provided.
|
|
| Locked | Locked | Locked |
Cell therapies are developed using proprietary Cell Squeeze technology.
|
|
| Locked | Locked | Locked |
Microfluidics-based tools for cellular analysis are provided.
|
|
| Locked | Locked | Locked |
Microfluidics-based systems for single-cell isolation and analysis are developed.
|
|
| Locked | Locked | Locked |
Developer of AI-based automated solutions for the preparation and analysis of microbiology culture specimens
|
|
| Locked | Locked | Locked |
Supplement reagents for cell and gene therapy are manufactured.
|
Detailed competitors of Stamm Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stamm Biotech
Complete news archive for Stamm Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stamm Biotech
Stamm Biotech was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Stamm Biotech is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Stamm Biotech is a funded company, having raised a total of $17.25M across 2 funding rounds to date.
Stamm Biotech was founded in 2017 and is based in San Francisco, United States. Operations focus on the biotechnology sector, where cell processing platforms are designed and developed as bioproduction systems. These platforms track biological, physical, and chemical variations within bioprocessors. Strain behavior in bioreactors is predicted through this monitoring, supporting applications in research and industrial settings.
Stamm Biotech's top competitors include MaxCyte, SQZBiotech and Mytos.
Stamm Biotech offers Bioprocessor, Bioengineering Solutions, and Bio AI Pipelines.
Stamm Biotech has 12 investors. Key investors include GRIDX, Vista Equity Partners, Abundance Venture Capital, Trillian, and Teramips Technologies.